Literature DB >> 34921647

Anti-obesity and Gut Microbiota Modulation Effect of Astragalus Polysaccharides Combined with Berberine on High-Fat Diet-Fed Obese Mice.

Shi-Jun Yue1,2, Wen-Xiao Wang2, Lei Zhang1, Juan Liu1, Wu-Wen Feng1, Huan Gao2, Yu-Ping Tang2, Dan Yan3,4.   

Abstract

OBJECTIVE: To investigate whether astragalus polysaccharides (APS) combined with berberine (BBR) can reduce high-fat diet (HFD)-induced obesity in mice.
METHODS: Except for normal mice, 32 HFD-induced obese mice were randomized into HFD, APS (1,000 mg/kg APS), BBR (200 mg/kg BBR), and APS plus BBR (1,000 mg/kg APS plus 200 mg/kg BBR) groups, respectively. After 6-week treatment (once daily by gavage), the obesity phenotype and pharmacodynamic effects were evaluated by histopathological examination of epididymal fat, liver, and colon using hematoxylin-eosin staining and serum biochemical analyses by an automated chemistry analyzer. The feces were collected at the 12 th week, and taxonomic and functional profiles of gut microbiota were analyzed by 16S ribosomal ribonucleic acid (16S rRNA) sequencing.
RESULTS: Compared with HFD group, the average body weight of APS plus BBR group was decreased (P<0.01), accompanied with the reduced fat accumulation, enhanced colonic integrity, insulin sensitivity and glucose homeostasis (P<0.05 or P<0.01). Importantly, APS combined with BBR treatment was more effective than APS or BBR alone in improving HFD-induced insulin resistance (P<0.05 or P<0.01). 16S rRNA sequence-based analysis of fecal samples demonstrated that APS combined with BBR treatment exhibited a better impact on HFD-induced gut microbiota dysbiosis, exclusively via the enriched abundances of Bacteroides, which corresponded to the large increase of predicted bacterial genes involved in carbohydrate metabolism.
CONCLUSION: APS combined with BBR may synergistically reduce obesity and modulate the gut microbiota in HFD-fed mice.
© 2021. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Astragalus polysaccharides; Bacteroides; berberine; gut microbiota; obesity

Year:  2021        PMID: 34921647     DOI: 10.1007/s11655-021-3303-z

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  3 in total

1.  APS could potentially activate hepatic insulin signaling in HFD-induced IR mice.

Authors:  Jie Sun; Yan Liu; Jinhui Yu; Jin Wu; Wenting Gao; Liyuan Ran; Rujiao Jiang; Meihua Guo; Dongyu Han; Bo Liu; Ning Wang; Youwei Li; He Huang; Li Zeng; Ying Gao; Xin Li; Yingjie Wu
Journal:  J Mol Endocrinol       Date:  2019-07       Impact factor: 5.098

2.  Astragalus polysaccharides attenuates TNF-α-induced insulin resistance via suppression of miR-721 and activation of PPAR-γ and PI3K/AKT in 3T3-L1 adipocytes.

Authors:  Bin Ke; Xiao Ke; Xuesi Wan; Yubin Yang; Yingjuan Huang; Jian Qin; Chengheng Hu; Lin Shi
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  Effect of Astragalus membranaceus extract on diabetic nephropathy.

Authors:  Jiman Kim; Eulsun Moon; Seungwon Kwon
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2014-09-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.